Display options
Share it on

Evid Based Complement Alternat Med. 2011;2011:140462. doi: 10.1155/2011/140462. Epub 2011 Aug 04.

Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway.

Evidence-based complementary and alternative medicine : eCAM

Chen Zhang, Yong Li, Zhong-Ji Qian, Sang-Hoon Lee, Yong-Xin Li, Se-Kwon Kim

Affiliations

  1. Department of Chemistry, Pukyong National University, Busan 608-737, Republic of Korea.

PMID: 21826183 PMCID: PMC3151525 DOI: 10.1155/2011/140462

Abstract

The matrix metalloproteinase (MMP) family is involved in the breakdown of extracellular matrix in normal physiological processes, as well as in the disease processes such as arthritis and cancer metastasis. In the present study, dieckol was obtained with high yield from marine brown alga Ecklonia cava (EC), and its effect was assessed on the expression of MMP-2 and -9 and morphological changes in human fibrosarcoma cell line (HT1080). Dieckol inhibited the expression of MMP-2 and -9 in a dose-dependent manner and also suppressed the cell invasion and the cytomorphology in 3D culture system on HT1080 cells. Moreover, dieckol may influence nuclear factor kappa B (NF-κB) pathway without obvious influence on activator protein-1 (AP-1) pathway and tissue inhibitor of metalloproteinases (TIMPs). In conclusion, dieckol could significantly suppress MMP-2 and -9 expression and alter cytomorphology of HT1080 cell line via NF-κB pathway.

References

  1. J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27 - PubMed
  2. Evid Based Complement Alternat Med. 2004 Dec;1(3):215-217 - PubMed
  3. Arch Biochem Biophys. 2004 Jan 15;421(2):267-76 - PubMed
  4. J Biol Chem. 2002 Aug 16;277(33):30271-82 - PubMed
  5. J Biol Chem. 1983 Oct 25;258(20):12252-8 - PubMed
  6. Pathol Oncol Res. 2001;7(1):14-23 - PubMed
  7. Biochem Biophys Res Commun. 2005 May 20;330(4):1306-13 - PubMed
  8. Int J Cancer. 2003 Jun 20;105(3):291-9 - PubMed
  9. J Med Food. 2010 Feb;13(1):31-8 - PubMed
  10. J Biol Chem. 2001 Jan 12;276(2):1164-72 - PubMed
  11. Evid Based Complement Alternat Med. 2010 Mar;7(1):47-56 - PubMed
  12. Ann N Y Acad Sci. 1999 Jun 30;878:335-46 - PubMed
  13. J Med Food. 2009 Jun;12(3):601-7 - PubMed
  14. Life Sci. 2008 Feb 27;82(9-10):467-76 - PubMed
  15. Arch Pharm Res. 2004 Feb;27(2):194-8 - PubMed
  16. Mol Med Today. 2000 Apr;6(4):149-56 - PubMed
  17. Life Sci. 2006 Sep 5;79(15):1436-43 - PubMed
  18. Science. 2001 Nov 23;294(5547):1708-12 - PubMed
  19. Exp Neurol. 2005 Mar;192(1):1-6 - PubMed
  20. Cancer Detect Prev. 2005;29(3):260-6 - PubMed
  21. Cell. 2003 Jul 11;114(1):33-45 - PubMed
  22. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  23. Biochem Pharmacol. 2004 Jul 15;68(2):361-71 - PubMed
  24. Circ Res. 1999 Aug 20;85(4):364-76 - PubMed
  25. Electrophoresis. 2007 Dec;28(24):4705-12 - PubMed
  26. Nature. 1993 Sep 9;365(6442):182-5 - PubMed
  27. Nature. 1990 Apr 12;344(6267):678-82 - PubMed
  28. J Cell Biochem. 2008 May 1;104(1):15-26 - PubMed
  29. Life Sci. 2006 Nov 25;79(26):2480-5 - PubMed
  30. Food Chem Toxicol. 2006 Nov;44(11):1890-6 - PubMed
  31. Bioorg Med Chem. 2008 Sep 1;16(17):7921-6 - PubMed
  32. Ann Rheum Dis. 2000 Jun;59(6):455-61 - PubMed
  33. Phytochemistry. 2007 Jul;68(14):2015-22 - PubMed
  34. J Biol Chem. 2004 Sep 17;279(38):39513-9 - PubMed
  35. FASEB J. 1999 May;13(8):781-92 - PubMed
  36. Cell Signal. 2010 Feb;22(2):212-20 - PubMed
  37. Mar Drugs. 2009 Mar 31;7(2):71-84 - PubMed
  38. Nat Rev Cancer. 2002 Sep;2(9):657-72 - PubMed

Publication Types